Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alfa-2b”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01066793
What this trial is testing

PROPHESYS 2: An Observational Study on Predictors of Response in Treatment-naïve Patients With Chronic Hepatitis C Treated With Pegasys (Peginterferon Alfa-2a) or Peginterferon-alfa-2b

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 2,343
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07468916
What this trial is testing

Ropeginterferon Alfa-2b for the Treatment of Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes and Chronic Myelomonocytic Leukemia

Who this might be right for
Atypical Chronic Myeloid LeukemiaChronic Myelomonocytic LeukemiaMyelodysplastic/Myeloproliferative Neoplasm+2 more
Jonsson Comprehensive Cancer Center 35
Large-scale testing (Phase 3)Study completedNCT00759109
What this trial is testing

Pegylated Alfa-2b Interferon Therapy of Patients With Hepatitis C-related Cirrhosis and High Liver Cell Proliferation (P02733/MK-4031-085)

Who this might be right for
Carcinoma, Hepatocellular
Merck Sharp & Dohme LLC 150
Not applicableStudy completedNCT00749684
What this trial is testing

Efficacy and Safety of High-dose Interferon Alfa-2b (Intron A®) for the Adjuvant Treatment of Malignant Melanoma (Study P04083)

Who this might be right for
Melanoma
Merck Sharp & Dohme LLC 138
Early research (Phase 1)Study completedNCT00217542
What this trial is testing

Azacitidine and Recombinant Interferon Alfa-2b in Treating Patients With Stage III or Stage IV Melanoma or Stage IV Kidney Cancer That Cannot Be Removed By Surgery

Who this might be right for
Recurrent MelanomaRecurrent Renal Cell CancerStage III Melanoma+2 more
National Cancer Institute (NCI) 42
Testing effectiveness (Phase 2)Study completedNCT00004104
What this trial is testing

Vaccine Therapy Plus Interleukin-2 With or Without Interferon Alfa-2b in Treating Patients With Stage III Melanoma

Who this might be right for
Melanoma (Skin)
NYU Langone Health
Large-scale testing (Phase 3)Study completedNCT01468584
What this trial is testing

Efficacy and Safety of MP-424, Peginterferon Alfa-2b and Ribavirin in Non-responder Genotype 2 Hepatitis C Infected Patients

Who this might be right for
Chronic Hepatitis C
Tanabe Pharma Corporation 10
Large-scale testing (Phase 3)Study completedNCT00237484
What this trial is testing

Effect of Infliximab on the Efficacy of Peg-Intron/Ribavirin in Patients With Hepatitis C (Study P04257AM4)(COMPLETED)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 89
Large-scale testing (Phase 3)Study completedNCT00301509
What this trial is testing

Antiviral Therapy in Decompensated Hepatitis C Virus (HCV) Cirrhosis

Who this might be right for
Liver Cirrhosis, Experimental
Casa Sollievo della Sofferenza IRCCS
Post-approval studies (Phase 4)Ended earlyNCT01606800
What this trial is testing

Efficacy and Safety of Short Course Therapy With Peginterferon Alpha-2b (PEG-IFN Alfa-2b) and Ribavirin (RBV) for Chronic Hepatitis C (Genotype 4) Participants Achieving a Rapid Virological Response at Week 4 of Treatment (MK-8908B-059)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 45
Early research (Phase 1)Study completedNCT00000694
What this trial is testing

A Phase I Trial of Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor (rHuGM-CSF), Recombinant Alpha Interferon and Azidothymidine (AZT) in AIDS-Associated Kaposi's Sarcoma

Who this might be right for
Sarcoma, KaposiHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 18
Early research (Phase 1)Study completedNCT03554005
What this trial is testing

Extended Administration of Polyethylene Glycol (PEG) Interferon Alfa-2b in Participants With Solid Tumors (C/I97-349/MK-4031-009)

Who this might be right for
Neoplasms
Merck Sharp & Dohme LLC 29
Testing effectiveness (Phase 2)Looking for participantsNCT06552429
What this trial is testing

Peginterferon α-2b Injection for Hydroxyurea Resistant or Intolerant ET

Who this might be right for
Essential Thrombocythemia
Xiamen Amoytop Biotech Co., Ltd. 27
Large-scale testing (Phase 3)Study completedNCT01760122
What this trial is testing

Efficacy and Safety of Peginterferon Alfa-2b in HBeAg Positive Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Xiamen Amoytop Biotech Co., Ltd. 820
Testing effectiveness (Phase 2)Study completedNCT00126594
What this trial is testing

Sorafenib Tosylate With or Without Recombinant Interferon Alfa-2b in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaRecurrent Renal Cell CarcinomaStage IV Renal Cell Cancer
National Cancer Institute (NCI) 80
Large-scale testing (Phase 3)Study completedNCT02218047
What this trial is testing

AOP2014 vs. BAT in Patients With Polycythemia Vera Who Previously Participated in the PROUD-PV Study.

Who this might be right for
Polycythemia Vera
AOP Orphan Pharmaceuticals AG 170
Large-scale testing (Phase 3)UnknownNCT01653236
What this trial is testing

Boceprevir With Peginterferon Alfa-2b and Ribavirin in the Treatment-naive Patients Infected With Genotype 4 Chronic Hepatitis C Infection

Who this might be right for
Genotype 4 Chronic Hepatitis C Infection
Theodor Bilharz Research Institute 40
Not applicableStudy completedNCT00227149
What this trial is testing

Long-Term Evaluation Follow-up of Neurocognitive Performance and Emotional State in Patients With Chronic Hepatitis C

Who this might be right for
Hepatitis C, Chronic
University of Wuerzburg 197
Large-scale testing (Phase 3)Study completedNCT00002882
What this trial is testing

Interferon Alfa With or Without Combination Chemotherapy Plus Interleukin-2 in Treating Patients With Melanoma

Who this might be right for
MelanomaSkin Cancer
M.D. Anderson Cancer Center 140
Post-approval studies (Phase 4)Study completedNCT02360592
What this trial is testing

Combination Therapy With Interferon Plus Interleukin 2 and Hepatitis B Vaccine in Chronic Hepatitis B Patients

Who this might be right for
Hepatitis B, Chronic
Tongji Hospital 94
Next Page